Gujarat Terce Laboratories Reports Q2 Results with Sequential Turnaround to Profit
Gujarat Terce Laboratories Ltd · Financial Result · 05 Nov 2026, 10:25 pm
Gujarat Terce Laboratories Reports Q2 Results with Sequential Turnaround to Profit Gujarat Terce Laboratories reported standalone revenue from operations of ₹1,277.71 lakh for the quarter ended 30th Sep'26, rising 41.9% QoQ from ₹900.24 lakh but slipping 1.2% YoY from ₹1,292.63 lakh. Net profit stood at ₹131.92 lakh, rebounding from a loss of ₹17.81 lakh in the previous quarter and slightly below ₹140.36 lakh in the prior-year period. Basic EPS reached ₹1.69. For H1'26, operational revenue totaled ₹2,177.95 lakh with net profit of ₹114.11 lakh and operating cash flow of ₹390.32 lakh.
Original exchange filing (PDF)
More announcements from Gujarat Terce Laboratories Ltd
- Detailed disclosure is attached. · 05 Nov 2026
- In compliance with Regulation 30 read with Schedule III, Regulation 33 and other applicable provisions of the SEBI Listing Regulations, the Board of Directors of Gujarat Terce Laboratories .... · 05 Nov 2026
- Gujarat Terce Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve The Unaudited Standalone .... · 05 Nov 2026
- Detailed disclosure is attached · 21 Aug 2026
- Detailed disclosure is attached. · 21 Aug 2026
- Detailed disclosure is attached. · 21 Aug 2026
- Corrigendum/Revised intimation regarding Re-appointment of Managing Director & Chief Executive Officer of the Company- Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) .... · 21 Aug 2026
- Detailed disclosure is attached. · 07 Aug 2026
